Methylprednisolone Taper, Lower Extremity
Phase 4
Recruiting
- Conditions
- Knee Arthritis
- Registration Number
- NCT05859269
- Lead Sponsor
- Emory University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Inclusion Criteria:<br><br> - Patients undergoing primary total knee arthroplasty for osteoarthritis of the knee.<br><br> - Patients of the ages of 18 and 95 years.<br><br>Exclusion Criteria:<br><br> - Patients with concurrent and significant injuries to other bones or organs.<br><br> - Minors unable to consent for participation in the study.<br><br> - Subjects who, in the opinion of the investigator, may be non-compliant with study<br> schedules or procedures.<br><br> - Patients with pre-existing immune suppression, where further immune suppression with<br> glucocorticoids could warrant unwarranted or unneeded risk.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in Pain Score during Follow up period;Changes in Nausea score during Follow Up Period
- Secondary Outcome Measures
Name Time Method Changes in the postoperative range of motion following total knee arthroplasty (TKA);Changes in post operative knee function utilizing Knee injury and Osteoarthritis Outcome Score (KOOS);Compare patient satisfaction with acute postoperative pain control;Compare the postoperative opiate consumption measured as the number of tablets taken